Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dki381DOI Listing

Publication Analysis

Top Keywords

susceptibility pneumococci
4
pneumococci causing
4
causing meningitis
4
meningitis england
4
england wales
4
wales first-line
4
first-line antimicrobial
4
antimicrobial agents
4
agents 2001-2004
4
susceptibility
1

Similar Publications

Determination of antimicrobial resistance (AMR) in pneumococcal isolates is important for surveillance purposes and in a clinical context. Antimicrobial susceptibility testing (AST) of pneumococci is complicated by the need for exact minimal inhibitory concentrations (MICs) of beta-lactam antibiotics. Two next-generation sequencing (NGS) analysis tools have implemented the prediction of AMR in their analysis workflow, including the prediction of MICs: Pathogenwatch (https://pathogen.

View Article and Find Full Text PDF

Changes in population genetic structure of serotype 19A Streptococcus pneumoniae after universal childhood use of the 10-valent pneumococcal conjugate vaccine in Brazil.

Vaccine

December 2024

Instituto Biomédico, Universidade Federal Fluminense, Alameda Barros Terra, s/n, São Domingos, Niterói, RJ 24020-150, Brazil. Electronic address:

Article Synopsis
  • The introduction of the 10-valent pneumococcal conjugate vaccine (PCV10) in Brazil has significantly decreased the prevalence of vaccine serotype-related invasive pneumococcal disease (IPD) in children, but non-vaccine serotypes, particularly 19A, have become more prominent.
  • The study analyzed 32 serotype 19A isolates from a variety of patients, finding that the majority of these isolates came from children and displayed high levels of non-susceptibility to commonly used antibiotics.
  • A significant number of the isolates were multidrug resistant, with a notable shift in genetic lineages, indicating evolving resistance patterns following the introduction of PCV10.
View Article and Find Full Text PDF

Background: Streptococcus pneumoniae (pneumococcus) is a common cause of respiratory and invasive infections in humans. PCV13, a pneumococcal conjugate vaccine used globally, is highly effective against diseases caused by pneumococcal serotypes included in its formulation. However, one of them, the serotype 3 (ST3) is still being relatively commonly isolated from patients, suggesting an escape from vaccine-induced immunity.

View Article and Find Full Text PDF
Article Synopsis
  • Streptococcus pneumoniae is a significant global health threat, but pneumococcal conjugate vaccines (PCVs) have notably decreased cases of targeted serotypes.
  • Research conducted over 41 years in Norway utilized whole-genome sequencing to analyze historical and contemporary isolates of S. pneumoniae, revealing shifts in serotype populations.
  • Findings indicate that while PCVs have decreased invasive disease, they also led to some serotype switching to non-vaccine types, indicating a dynamic evolutionary response in the bacterial population.
View Article and Find Full Text PDF

To describe the profile of , identify research gaps, and provide in-depth insights into various aspects related to the pathogen. Google Scholar, PubMed, and ScienceDirect were searched for all studies on the pneumococcus in Ghana that reported on specimen collected, population and sample size, carriage prevalence, incidence of pneumococcal diseases, age of the study population, types of test performed, serotypes identified, antimicrobial susceptibilities, or molecular analysis on the pneumococci for data extraction. Overall, a total of 7954 results were obtained from the three-database search, and of this, 24 articles were selected after screening.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!